GRISELDA BEAUVAIS: Open Payments
NPI 1184481335 · VENTURA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,667 in 57 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $512 · 2025 $1,667
Food & beverage: $1,582Education: $85
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 12 | $418 |
| ABBVIE INC. | 11 | $324 |
| QOL Medical, LLC | 9 | $177 |
| Phathom Pharmaceuticals, Inc. | 2 | $149 |
| Regeneron Healthcare Solutions, Inc. | 4 | $136 |
| Gilead Sciences, Inc. | 4 | $104 |
| Madrigal Pharmaceuticals | 3 | $78 |
| PFIZER INC. | 2 | $55 |
| Novo Nordisk Inc | 3 | $51 |
| GENZYME CORPORATION | 2 | $44 |
Products named: TREMFYA, CREON, DUPIXENT, Sucraid, VOQUEZNA, REZDIFFRA, LINZESS, XIFAXAN.
Industry payments across CA — which companies pay providers there.
